NASDAQ:IQMDU Intelligent Medicine Acquisition (IQMDU) Stock Price, News & Analysis → get a piece of the profit from this land (From True Market Insiders) (Ad) Free IQMDU Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.90▼$11.0050-Day Range$10.12▼$10.9852-Week Range$9.90▼$11.00Volume3,200 shsAverage Volume4,777 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Intelligent Medicine Acquisition alerts: Email Address Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. About Intelligent Medicine AcquisitionIntelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.Read More Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. IQMDU Stock News HeadlinesFebruary 14, 2024 | forbes.comRevolutionizing Healthcare: The Integral Role Of AI And IoT In Shaping Modern MedicineNovember 15, 2023 | morningstar.comDeep Medicine Acquisition Corp Class ASeptember 15, 2023 | finance.yahoo.comiMocha's Skills Intelligence for Total Talent Acquisition Now Available on SAP® StoreAugust 25, 2023 | finance.yahoo.comArtificial Intelligence In Precision Medicine Research Report 2023: Enhanced Patient Care Fuels Growth - Forecast to 2030March 29, 2023 | marketwatch.comArtificial Intelligence in Medicine Market 2023: Growing Opportunities by 2028February 16, 2023 | nasdaq.comLighthouse Investment Partners Now Owns 5.83% of Deep Medicine Acquisition Corp - (DMAQ)February 8, 2023 | finance.yahoo.com12 NASDAQ Penny Stocks Under 10 CentsFebruary 3, 2023 | finance.yahoo.comIntelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of StockholdersSeptember 21, 2022 | investing.comDeep Medicine Acquisition Corp (DMAQ)July 8, 2022 | finance.yahoo.comArtificial Intelligence in Genomics Market to Witness a Staggering CAGR of 50.2% and Accumulate Revenue of USD 18,213 Million by 2030June 24, 2022 | finance.yahoo.comMiddle East $8.62 Billion Precision Medicine Markets to 2032: Targeted Gene Therapy & Expansion into Emerging Markets Presents OpportunitiesApril 5, 2022 | finance.yahoo.comWhat Type Of Shareholders Make Up Intelligent Medicine Acquisition Corp.'s (NASDAQ:IQMD) Share Registry?January 5, 2022 | investing.comIntelligent Medicine Acquisition Corp Unit (IQMDU)December 26, 2021 | yahoo.comCentral Ohio high school sports scores, Dec. 20-26December 23, 2021 | finance.yahoo.comIntelligent Medicine Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 27, 2021December 9, 2021 | finance.yahoo.comIntelligent Medicine Acquisition Corp. Announces Pricing of Upsized $180,000,000 Initial Public OfferingDecember 9, 2021 | finance.yahoo.comIntelligent Medicine Acquisition Corp. Announces Closing of Upsized $207,000,000 Initial Public OfferingSee More Headlines Receive IQMDU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Medicine Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry Shell Companies Sub-IndustryN/A Current SymbolNASDAQ:IQMDU CUSIPN/A CIK1850051 WebN/A PhoneN/AFaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Gregory C. Simon (Age 70)CEO, CFO & Director Key Competitors99 Acquisition GroupNASDAQ:NNAGU99 Acquisition GroupNASDAQ:NNAGWA SPAC II AcquisitionNASDAQ:ASCBUA SPAC II AcquisitionNASDAQ:ASCBWAce Global Business AcquisitionNASDAQ:ACBAWView All Competitors IQMDU Stock Analysis - Frequently Asked Questions When did Intelligent Medicine Acquisition IPO? Intelligent Medicine Acquisition (IQMDU) raised $180 million in an initial public offering (IPO) on Friday, November 5th 2021. The company issued 18,000,000 shares at a price of $10.00 per share. This page (NASDAQ:IQMDU) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Medicine Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
